휴온스글로벌

084110KOSDAQ

69.3 / 100

Reference Date: 2026-09-08

Financial Score28.0 / 40

News Sentiment17.3 / 25

Momentum9.0 / 20

Disclosure15.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Declined 5.0% over the past month, and news sentiment is negative.

Company InformationBased on 2025 Annual Report

Business Overview

Hyunohs Global is a holding company under the Hyunohs Group, managing 13 subsidiaries across pharmaceuticals, medical devices, biopharmaceuticals, and health supplements. Key operations include Hyunohs' pharmaceutical manufacturing, Hyunmedics' botulinum toxin and filler development, Hyunohs Biopharma's biopharmaceutical research, and Hyunohs Meditech's medical device production. Primary revenue streams include brand royalties and dividends from subsidiaries.

Number of Employees

121people

Average Salary

62.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

9.97Industry Average 15.006.5Point

Lower than industry avg (good)

PBR

0.27Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

7.96Industry Average 8.002.5Point

Below industry avg

Debt Ratio

13.66Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲5.7% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼10.8% (2-year basis)

ROE Trend

2.0 / 4

Avg ROE 8.7% (declining, 3yr)

Detailed News Sentiment

13 totalPositive 6Neutral 0Negative 7Average Sentiment Score 69.2

Negative
[인사이드 스토리]휴온스·랩 합병 철회…매수청구권 어땠길래
휴온스글로벌의 자회사 합병 철회로 인해 재무 부담 증가와 주주 반발이 예상되어 부정적 영향이 예상됩니다.
Positive
정맥주사 항체약 ‘피하주사 전환’ 겨냥?휴온스랩, 11종 조성물 특허
휴온스랩의 특허 획득으로 피하주사 전환 기술 개발이 진전되어 휴온스글로벌의 신약 개발 역량 강화 기대.
Positive
휴온스랩 “하이디퓨즈 적용 항체, 조성물 특허 등록”
휴온스랩의 특허 등록으로 SC 제형 개발 성공, 기술 혁신과 시장 경쟁력 강화 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (5%, downtrend)

Current 23,600Won52-week high 75,30052-week low 20,600

1-month return2.0Point

1m -5.03% (slight drop)

Volume trend6.0Point

Volume surge

Detailed Disclosure

12 totalPositive 5Neutral 7Negative 0

Neutral[기재정정]주요사항보고서(회사합병결정)(자회사의 주요경영사항) (철회)2026-08-26
Neutral기타주요경영사항 (임시주주총회 소집결의 철회)2026-08-26
Positive[기재정정]수시공시의무관련사항(공정공시) (주주가치 제고를 위한 현물배당 계획 안내-철회)2026-08-26
Neutral[기재정정]주주총회소집결의 (임시주주총회-철회)2026-08-26
Neutral[기재정정]주주총회소집공고2026-08-26